drugset / Trial / NCT04044339
Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a Phase 1, randomized, double-blinded, placebo controlled study. The study consists of 2 parts: Part A is a single ascending dose (SAD) study in healthy subjects and Part B is a multiple ascending dose (MAD) study in healthy subjects.
Timeline
- Start
- 2019-08-08
- Primary completion
- 2019-11-27
- Completion
- 2019-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TD-5202 | Unknown | — | Oral |
Indications
No indication recorded.